227 related articles for article (PubMed ID: 24742740)
1. Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial.
Zhu HD; Guo JH; Mao AW; Lv WF; Ji JS; Wang WH; Lv B; Yang RM; Wu W; Ni CF; Min J; Zhu GY; Chen L; Zhu ML; Dai ZY; Liu PF; Gu JP; Ren WX; Shi RH; Xu GF; He SC; Deng G; Teng GJ
Lancet Oncol; 2014 May; 15(6):612-9. PubMed ID: 24742740
[TBL] [Abstract][Full Text] [Related]
2. Radioactive self-expanding stents for palliative management of unresectable esophageal cancer: a systematic review and meta-analysis.
Chen HL; Shen WQ; Liu K
Dis Esophagus; 2017 May; 30(5):1-16. PubMed ID: 28375442
[TBL] [Abstract][Full Text] [Related]
3. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer.
Guo JH; Teng GJ; Zhu GY; He SC; Fang W; Deng G; Li GZ
Radiology; 2008 May; 247(2):574-81. PubMed ID: 18349316
[TBL] [Abstract][Full Text] [Related]
4. Radioactive self-expanding stents give superior palliation in patients with unresectable cancer of the esophagus but should be used with caution if they have had prior radiotherapy.
Liu N; Liu S; Xiang C; Cong N; Wang B; Zhou B; Zhang B; Li Y; Wang Y; Yuan S
Ann Thorac Surg; 2014 Aug; 98(2):521-6. PubMed ID: 24841543
[TBL] [Abstract][Full Text] [Related]
5. Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial.
Adamson D; Byrne A; Porter C; Blazeby J; Griffiths G; Nelson A; Sewell B; Jones M; Svobodova M; Fitzsimmons D; Nixon L; Fitzgibbon J; Thomas S; Millin A; Crosby T; Staffurth J; Hurt C
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):292-303. PubMed ID: 33610215
[TBL] [Abstract][Full Text] [Related]
6. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.
Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
Lancet; 2004 Oct 23-29; 364(9444):1497-504. PubMed ID: 15500894
[TBL] [Abstract][Full Text] [Related]
7. Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicenter trial.
Zhu HD; Guo JH; Huang M; Ji JS; Xu H; Lu J; Li HL; Wang WH; Li YL; Ni CF; Shi HB; Xiao EH; Lv WF; Sun JH; Xu K; Han GH; Du LA; Ren WX; Li MQ; Mao AW; Xiang H; Zhang KX; Min J; Zhu GY; Su C; Chen L; Teng GJ
J Hepatol; 2018 May; 68(5):970-977. PubMed ID: 29331343
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with overall survival and relief of dysphagia in advanced esophageal cancer patients after 125I seed-loaded stent placement: a multicenter retrospective analysis.
Qin J; Zhu HD; Guo JH; Ni CF; Wu P; Xu H; Mao AW; Lu J; Su C; Teng GJ
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30888392
[TBL] [Abstract][Full Text] [Related]
9. Interventions for dysphagia in oesophageal cancer.
Dai Y; Li C; Xie Y; Liu X; Zhang J; Zhou J; Pan X; Yang S
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005048. PubMed ID: 25354795
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of self-expanding metal stent and intraluminal radioactive stent for inoperable esophageal squamous cell carcinoma.
Tian D; Wen H; Fu M
World J Surg Oncol; 2016 Jan; 14(1):18. PubMed ID: 26800661
[TBL] [Abstract][Full Text] [Related]
11. Intraluminal radioactive stent compared with covered stent alone for the treatment of malignant esophageal stricture.
Zhongmin W; Xunbo H; Jun C; Gang H; Kemin C; Yu L; Fenju L
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):351-8. PubMed ID: 21431967
[TBL] [Abstract][Full Text] [Related]
12. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.
Hurvitz SA; Andre F; Jiang Z; Shao Z; Mano MS; Neciosup SP; Tseng LM; Zhang Q; Shen K; Liu D; Dreosti LM; Burris HA; Toi M; Buyse ME; Cabaribere D; Lindsay MA; Rao S; Pacaud LB; Taran T; Slamon D
Lancet Oncol; 2015 Jul; 16(7):816-29. PubMed ID: 26092818
[TBL] [Abstract][Full Text] [Related]
13. Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial.
von Birgelen C; Sen H; Lam MK; Danse PW; Jessurun GA; Hautvast RW; van Houwelingen GK; Schramm AR; Gin RM; Louwerenburg JW; de Man FH; Stoel MG; Löwik MM; Linssen GC; Saïd SA; Nienhuis MB; Verhorst PM; Basalus MW; Doggen CJ; Tandjung K
Lancet; 2014 Feb; 383(9915):413-23. PubMed ID: 24183564
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer.
Touchefeu Y; Archambeaud I; Landi B; Lièvre A; Lepère C; Rougier P; Mitry E
Dig Liver Dis; 2014 Mar; 46(3):283-6. PubMed ID: 24268567
[TBL] [Abstract][Full Text] [Related]
15. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer--results of a prospective safety study.
Bergquist H; Johnsson E; Nyman J; Rylander H; Hammerlid E; Friesland S; Ejnell H; Lundell L; Ruth M
Dis Esophagus; 2012 Jul; 25(5):410-5. PubMed ID: 21899654
[TBL] [Abstract][Full Text] [Related]
16. Outcomes following oesophageal stent insertion for palliation of malignant strictures: A large single centre series.
Battersby NJ; Bonney GK; Subar D; Talbot L; Decadt B; Lynch N
J Surg Oncol; 2012 Jan; 105(1):60-5. PubMed ID: 22161899
[TBL] [Abstract][Full Text] [Related]
17. Interventions for dysphagia in oesophageal cancer.
Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
[TBL] [Abstract][Full Text] [Related]
18. A New Fully Covered Irradiation Stent Versus a Partially Covered Irradiation Stent for Unresectable Malignant Dysphagia: A Single-Center Experience.
Wang C; Lu J; Wang Y; Zhu GY; Chen L; Li JC; Li TK; Chen L; Guo JH
Cardiovasc Intervent Radiol; 2019 Aug; 42(8):1142-1152. PubMed ID: 31144010
[TBL] [Abstract][Full Text] [Related]
19. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.
Hirdes MM; van Hooft JE; Wijrdeman HK; Hulshof MC; Fockens P; Reerink O; van Oijen MG; van der Tweel I; Vleggaar FP; Siersema PD
Gastrointest Endosc; 2012 Aug; 76(2):267-74. PubMed ID: 22695208
[TBL] [Abstract][Full Text] [Related]
20. [Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study].
Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2800-6. PubMed ID: 16385833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
